XORTX Therapeutics Inc. (XRTX) Ownership
XRTX ownership summary
as of October 18, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 1.53% of shares outstanding
- Shares outstanding
- 1.8M
- Float
- 1.8M shares available to trade
- Short interest
- 3.44% 62K shares short
- Days to cover
- 0.10 short interest down 19.8% vs prior month
- Institutions 0.01%
- Insiders 1.53%
- Other investors 98.46%
XRTX top institutional holders
11 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Citadel Advisors Llc | 1.27% | 23K | $28,664 | +23,116 (0.0%) | June 30, 2026 |
| 2 | StoneX Group Inc | 0.90% | 16K | $20,298 | +16,369 (0.0%) | June 30, 2026 |
| 3 | Royal Bank of Canada | 0.04% | 732 | $908 | +732 (0.0%) | June 30, 2026 |
| 4 | NATIONAL BANK OF CANADA /FI/ | 0.01% | 162 | $201 | +162 (0.0%) | June 30, 2026 |
| 5 | Hartland & Co | <0.01% | 55 | $68 | — | June 30, 2026 |
| 6 | TD Waterhouse Canada Inc | <0.01% | 9 | $11 | +9 (0.0%) | June 30, 2026 |
| 7 | DRW Securities, LLC | 0.00% | — | — | −193,599 (−100.0%) | March 31, 2026 |
| 8 | Kingsview Wealth Management, LLC | 0.00% | — | — | −3,000 (−100.0%) | June 30, 2026 |
| 9 | Baader Bank INC | 0.00% | — | — | −18,732 (−100.0%) | March 31, 2026 |
| 10 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −12,597 (−100.0%) | March 31, 2026 |
| 11 | UBS Group AG | 0.00% | — | — | −1,401 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 11, 5 holders added 40K shares and 5 cut 229K.
XRTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns XRTX
Institutional investors own 0.0% of XORTX Therapeutics's shares and insiders 1.53%. The largest holder is Citadel Advisors Llc with 1.27% of the shares (23K), as of June 30, 2026. Among the top 11 institutions, 5 added shares and 5 reduced their stake in the latest filings. Short interest is 3.44% of the float, or 0.10 days of average trading volume. The share count rose 40,903.1% since 2014.
Related: XRTX analyst forecast, XRTX key metrics. See the XRTX stock overview for the latest quote and news.
XRTX ownership FAQ
Who owns the most XORTX Therapeutics stock?
The largest shareholders of XORTX Therapeutics are Citadel Advisors Llc (1.27%), StoneX Group Inc (0.90%), Royal Bank of Canada (0.04%), NATIONAL BANK OF CANADA /FI/ (0.01%), Hartland & Co (<0.01%).
What percentage of XORTX Therapeutics is owned by institutions?
Institutions hold 0.0% of XORTX Therapeutics's shares outstanding; insiders hold 1.53%.
What is XORTX Therapeutics's short interest?
62K shares of XORTX Therapeutics were sold short, 3.44% of the float; at the average daily volume it would take 0.10 days to cover.
How many shares of XORTX Therapeutics are outstanding?
XORTX Therapeutics has 1.8M shares outstanding, of which 1.8M are in the public float.